Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1993
06/20/1993CA2085715A1 Aminosulfonic acid derivatives and processes for their preparation
06/20/1993CA2085713A1 Pharmaceutical compositions for peroral administration
06/20/1993CA2085687A1 New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
06/20/1993CA2084857A1 Saccharin derivative proteolytic enzyme inhibitors
06/20/1993CA2084531A1 Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
06/19/1993CA2085705A1 Pharmacologically active tricyclic derivatives
06/19/1993CA2085575A1 Imidazoles
06/19/1993CA2085532A1 Thiazoles
06/19/1993CA2085456A1 17beta-n-substituted adamantyl/norbornanyl carbamoyl-4-aza-5a -androst -1-en-3-ones and adrostan-3-ones as 5a-reductase inhibitors
06/19/1993CA2085094A1 Imidazopyridines
06/18/1993WO1993012072A1 Process for preparing optically active cyanohydrins with enzymes
06/18/1993CA2084798A1 Method of preventing prostatic carcinoma with 17beta -acyl-4-aza-5.- androst-1-ene-3-ones
06/17/1993DE4141746A1 20-methyl-substituierte vitamin d-derivate 20-methyl-substituted vitamin d derivatives
06/17/1993DE4141377A1 New pyridyl derivs. used as thromboxane inhibitors - used to treat arteriosclerosis, ischaemia, asthma, allergy systemic lupus, shock etc.
06/17/1993DE4140463A1 2'-desoxy-isoguanosin, dessen isostere analoge sowie anwendung derselben 2'-deoxy-isoguanosine, the isosteric analog and application thereof
06/17/1993DE4140183A1 Retardform fuer ein flurbiprofen enthaltendes arzneimittel und seine herstellung Release form for a drug-containing flurbiprofen and its manufacture
06/17/1993DE4140172A1 Retardform fuer ein ibuprofen enthaltendes arzneimittel und seine herstellung Release form for an ibuprofen-containing drug and its manufacture
06/17/1993CA2085557A1 Dihydropyrimidine derivatives
06/17/1993CA2085421A1 Pharmaceutical composition for the inhibition of bone resorption
06/17/1993CA2085408A1 Indole and benzimidazole-substituted dihydropyrimidine derivatives
06/17/1993CA2085399A1 Method for inhibiting nitric oxide formation
06/17/1993CA2085310A1 Substituted indole and benzimidazole derivatives
06/17/1993CA2085283A1 Inhibitors of farnesyl protein transferase
06/17/1993CA2085282A1 Inhibitors of farnesyl protein transferase
06/17/1993CA2084800A1 Hiv protease inhibitors with an internal lactam ring
06/17/1993CA2084796A1 Inhibitors of farnesyl protein transferase
06/17/1993CA2084795A1 Inhibitors of farnesyl protein transferase
06/16/1993EP0547000A1 Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound
06/16/1993EP0546875A2 New process for the preparation of 20-oxo, 17-alpha, 21-dihydroxy derivatives of pregnane and new intermediates thereof
06/16/1993EP0546870A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression
06/16/1993EP0546846A1 Programmed-release pharmaceutical compositions
06/16/1993EP0546796A1 Treatment of Atherosclerosis
06/16/1993EP0546763A1 Antitumor compositions and methods of treatment
06/16/1993EP0546687A2 Formazan parasiticides
06/16/1993EP0546676A1 Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
06/16/1993EP0546661A1 Pyrimidine derivatives, method for preparation thereof and pharmaceutical composition having said derivatives as active elements
06/16/1993EP0546593A1 Multi-layered compositions containing histamine or serotonin antagonists
06/16/1993EP0546591A2 11-beta-substituted 14,17-ethanoestratrienes, process for their production and their use in the preparation of medicines
06/16/1993EP0546583A1 Piperazinyl-and piperidinyl-cyclohexanols
06/16/1993EP0546548A1 Guanidinyl alkyl-1,1-bis phosphonic acid derivatives, process for their preparation and their use
06/16/1993EP0546547A1 Pharmaceutical composition for the improvement of dysuria
06/16/1993EP0546529A1 Triazole derivatives and salts thereof, processes for producing the same, and antifungal agent containing the same
06/16/1993EP0546475A1 Biologically active pseurotin A and D, new metabolites from Aspergillus fumigatus, process for their preparation and their use as apomorphine antagonists
06/16/1993EP0546474A1 Pseurotin F1/F2, new metabolites from Aspergillus fumigatus, process for their preparation and their use as apomorphine antagonists
06/16/1993EP0546449A2 Benzofuranderivatives as angiotensin II antagonists
06/16/1993EP0546389A1 Piperidylmethyl substituted chroman derivatives as agents for the treatment of diseases of the central nervous system
06/16/1993EP0546388A1 Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system
06/16/1993EP0546358A2 Pharmaceutical compositions with angiotensin-II-antagonistic activity
06/16/1993EP0546306A1 5-(2-Chloroalkyl)-4-methylthiazoles, their preparation and their use, and intermediates for their preparation
06/16/1993EP0546272A1 S-carboxymethylcysteine lysine salt monohydrate and a process for the preparation thereof
06/16/1993EP0546261A2 Method of treating latent herpes viral infections
06/16/1993EP0546179A1 4-o-(aminoglycosyl)- or 4,6-di-o-(aminoglycosyl)-2,5-dideoxy-5,5-difluorostreptamine derivative and production thereof
06/16/1993EP0546164A1 Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders
06/16/1993EP0546160A1 Method of reversing local anesthesia and reagent system therefor
06/16/1993EP0546123A1 Alpha-substituted tryptophane dipeptoid derivatives
06/16/1993EP0546122A1 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies
06/16/1993EP0546115A1 Peptides containing amino-polyols as transition-state mimics
06/16/1993EP0546108A1 Pro-drugs for cck antagonists
06/16/1993EP0546102A1 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases.
06/16/1993EP0546063A1 Toxic agent protective compounds, compositions and uses
06/16/1993EP0546005A1 1,2,5,6-tetrahydropyridine oxime derivatives
06/16/1993EP0545972A1 Therapeutically active mixture of glutathion and anthocyan compounds.
06/16/1993EP0531413A4 An antiviral composition
06/16/1993EP0486499A4 Stable ascorbic acid compositions
06/16/1993EP0406259B1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours
06/16/1993EP0352295B1 Biodadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents
06/16/1993EP0332679B1 Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections
06/16/1993EP0290558B1 Antifolate agents
06/16/1993EP0112332B1 Vitamin d glycosides
06/16/1993CN1073205A Prescription for compound red-rooted salvia wine and making method
06/16/1993CN1073179A Novel glycoside compounds and production and use thereof
06/16/1993CN1073177A New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process and their use as medicaments
06/16/1993CN1073174A Heterocyclic derivatives
06/16/1993CN1073173A Pharmaceuticals
06/16/1993CN1073172A Ethanol additive compound of 6-sulfonyl substituted 3-carboxy benzo dihydro-pyran and used as inhalant for patient
06/16/1993CN1073171A Derivative of quinoline, its preparation process and its application in medical treatment
06/16/1993CN1073169A 乙酸衍生物 Acetic acid derivatives
06/16/1993CN1073168A Benzothiazepine derivatives
06/16/1993CN1073166A Derivative of hydroximic acid
06/16/1993CN1073161A Endothelin receptor antagonists
06/16/1993CN1073096A Preparation for cantharidia liposoluble pharmaceutics
06/16/1993CN1073095A Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
06/16/1993CN1073094A Pharmaceutical composition containing felbinac
06/16/1993CN1021226C Preparation for acyl derivatives
06/16/1993CN1021225C Hydrate of penicillin derivative and process for preparing same
06/16/1993CN1021223C Process for 5-lipoxygense inhibiting 4-(4-phenyl-1-pip-erazing 1) phenols
06/16/1993CN1021222C Process for production of phthalazineacetic acid ester derivatives
06/16/1993CN1021196C Prepn. method of progestin unit and system
06/15/1993US5220068 Psychostimulant agent
06/15/1993US5220059 An N-amino-, hydroxy or thiocarbonyl or thiocarbonyl, N-hydroxyaminoalkylene derivative
06/15/1993US5220026 Antitumor agents
06/15/1993US5220017 Gastrointestinal, central nervous system disorders
06/15/1993US5220014 Inhibit protein synthesis
06/15/1993US5220002 Deacetylcolchicine derivatives
06/15/1993US5220001 Anthracycline glycoside derivatives
06/15/1993US5219889 Dietary supplementation with potassium magnesium citrate
06/15/1993US5219888 Increasing plasma high density lipoprotein levels
06/15/1993US5219887 Disinfecting shampoo composition for animals
06/15/1993US5219886 Cardiovascular disorders, analgesics, enzyme inhibitors
06/15/1993US5219885 Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration